The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1694
ISSUE1694
January 22, 2024
Perfluorohexyloctane Ophthalmic Solution (Miebo) for Dry Eye Disease
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Perfluorohexyloctane Ophthalmic Solution (Miebo) for Dry Eye Disease
January 22, 2024 (Issue: 1694)
The FDA has approved perfluorohexyloctane
ophthalmic solution (Miebo – Bausch+Lomb) for
treatment of dry eye disease. Available only by
prescription, Miebo is the first ophthalmic product to be approved in the US that specifically targets...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.